Asian Science Citation Index is committed to provide an authoritative, trusted and significant information by the coverage of the most important and influential journals to meet the needs of the global scientific community.  
ASCI Database
308-Lasani Town,
Sargodha Road,
Faisalabad, Pakistan
Fax: +92-41-8815544
Contact Via Web
Suggest a Journal
Articles by David W. Boyle
Total Records ( 1 ) for David W. Boyle
  Wei- Hua Shen , Zhuang Chen , Shu Shi , Hanying Chen , Wuqiang Zhu , Anne Penner , Guixue Bu , Wei Li , David W. Boyle , Michael Rubart , Loren J. Field , Robert Abraham , Edward A. Liechty and Weinian Shou
  Mammalian target of rapamycin (mTOR) is a key regulator for cell growth through modulating components of the translation machinery. Previously, numerous pharmacological studies using rapamycin suggested that mTOR has an important role in regulating cardiac hypertrophic growth. To further investigate this assumption, we have generated two lines of cardiac specific mTOR transgenic mice, kinase-dead (kd) mTOR and constitutively active (ca) mTOR, using α-myosin heavy chain promoter. α-Myosin heavy chain (αMHC)-mTORkd mice had a near complete inhibition of p70 S6k and 4E-BP1 phosphorylation, whereas αMHC-mTORca had a significant increase in p70 S6k and 4E-BP1 phosphorylation. Although the cardiac function of αMHC-mTORkd mice was significantly altered, the cardiac morphology of these transgenic mice was normal. The cardiac hypertrophic growth in response to physiological and pathological stimuli was not different in αMHC-mTORkd and αMHC-mTORca transgenic mice when compared with that of nontransgenic littermates. These findings suggest that the mTOR-mediated signaling pathway is not essential to cardiac hypertrophic growth but is involved in regulating cardiac function. Additional analysis of cardiac responses to fasting-refeeding or acute insulin administration indicated that αMHC-mTORkd mice had a largely impaired physiological response to nutrient energy supply and insulin stimulation.
Copyright   |   Desclaimer   |    Privacy Policy   |   Browsers   |   Accessibility